HealthLynked Corp
HealthLynked Corp
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | 0 | 6 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Contract With Customer Asset Gross Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 6 | |||||
Deposits Assets Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 | - | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Other Accrued Liabilities Cur… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 1 | 2 | |||||
Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Other Notes Payable Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Liabilities Current | 9 | 8 | 7 | 7 | 6 | 6 | 5 | 4 | 3 | 3 | 2 | 3 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |||||
Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Government Assistance Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - | - | - | - | |||||
Liabilities | 9 | 9 | 7 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 3 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 44 | 44 | 43 | 42 | |||||
Retained Earnings Accumulated Deficit | -53 | -52 | -51 | -51 | -50 | -49 | -48 | -47 | -45 | -43 | -42 | -41 | |||||
Stockholders Equity | -8 | -7 | -6 | -5 | -5 | -4 | -3 | -2 | -0 | 0 | 1 | 2 | |||||
Liabilities And Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 6 | |||||
Series B Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Unamortized Debt Issuance Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 50.41% | 76.56% | 59.15% | - | - | - | - | - | - | - | - | - |
| 2025 | -16.67% | 25.00% | 54.17% | -29.80% | -36.00% | -44.40% | 34.75% | 52.48% | 119.86% | -16.16% | -36.90% | 5.11% |
| 2024 | -1.85% | 44.44% | 38.89% | -30.00% | -44.29% | -52.86% | 0.00% | -36.67% | 126.67% | -17.24% | -31.03% | -37.93% |
| 2023 | - | - | - | - | - | - | -11.36% | 54.55% | 11.36% | -14.29% | -20.63% | 33.33% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.17 | 0.19 | 0.22 | 0.23 | 0.25 | 0.28 | 0.35 | 0.48 | 0.59 | 0.70 | 0.27 | 0.66 | |||||
| Quick Ratio | 0.17 | 0.18 | 0.21 | 0.22 | 0.24 | 0.27 | 0.33 | 0.45 | 0.55 | 0.64 | 0.19 | 0.59 | |||||
| Working Capital | -7.35M | -6.66M | -5.46M | -5.20M | -4.57M | -4.03M | -3.05M | -1.98M | -1.39M | -798.22K | -1.76M | -1.16M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.21 | -1.23 | -1.30 | -1.32 | -1.39 | -1.50 | -1.71 | -2.43 | -10.09 | 16.57 | 4.32 | 2.64 | |||||
| Debt Ratio | 5.87 | 5.32 | 4.38 | 4.08 | 3.57 | 3.01 | 2.41 | 1.70 | 1.11 | 0.94 | 0.81 | 0.73 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.80 | 0.93 | 1.05 | 1.05 | 0.90 | 0.93 | 0.93 | 0.79 | 0.90 | 1.01 | 1.26 | 0.91 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | 3.69 | 3.47 | 3.08 | 3.04 | 3.20 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | 99.00 | 105.19 | 118.62 | 120.12 | 113.89 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.36 | -1.34 | -1.16 | -1.35 | -1.76 | -2.06 | -2.18 | -2.19 | -1.56 | -1.37 | -0.39 | -1.64 | |||||
| Free Cash Flow Per Share TTM | -0.49 | -0.52 | -0.60 | -0.72 | -0.93 | -1.09 | -1.24 | -1.40 | -1.48 | -1.39 | -1.58 | -1.34 | |||||
| Dividend Per Share TTM | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 55.53% | 55.89% | 50.78% | 44.53% | 38.43% | 34.70% | 33.68% | 35.47% | 39.32% | 41.80% | 42.24% | 39.57% | |||||
| Operating Profit Margin TTM | 0.00% | 0.00% | 0.00% | -31.54% | -93.96% | -125.96% | -155.49% | -151.81% | -112.10% | -87.24% | -74.21% | -119.80% | |||||
| Net Profit Margin TTM | -291.95% | -226.70% | -158.83% | -161.50% | -192.39% | -208.57% | -203.81% | -186.32% | -108.02% | -78.64% | -18.09% | -72.56% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -46.73% | -38.29% | -31.35% | -28.51% | -36.61% | -43.28% | -46.22% | -44.66% | -31.49% | -14.54% | 3.46% | 10.01% | |||||
| Net Income Growth (1Y) | -19.16% | -32.92% | -46.50% | -38.03% | 12.91% | 50.44% | 505.76% | 42.10% | -26.40% | -41.19% | -88.96% | -32.33% | |||||
| EPS Growth (1Y) | -22.54% | -34.83% | -46.88% | -38.31% | 12.84% | 49.66% | 465.62% | 33.82% | -32.14% | -46.08% | -89.78% | -37.98% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -2.20 | -2.43 | -1.21 | -1.44 | -1.14 | -1.41 | -0.96 | -1.96 | -4.88 | -4.15 | -20.00 | -2.93 | |||||
| P/B TTM | -1.14 | -1.34 | -0.69 | -1.02 | -1.19 | -1.98 | -1.89 | -6.27 | -50.44 | 72.18 | 25.15 | 8.17 | |||||
| P/S TTM | 6.43 | 5.50 | 1.92 | 2.33 | 2.19 | 2.94 | 1.97 | 3.65 | 5.27 | 3.26 | 3.62 | 2.12 | |||||
| Market Cap | 8.83M | 9.43M | 3.97M | 5.52M | 5.64M | 8.18M | 5.91M | 12.12M | 21.42M | 15.99M | 20.24M | 12.74M | |||||
| Enterprise Value | 8.81M | 9.41M | 3.93M | 5.51M | 5.62M | 8.15M | 5.84M | 12.11M | 21.24M | 15.96M | 20.00M | 12.69M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -1.44M | -1.50M | -1.71M | -2.04M | -2.63M | -3.07M | -3.50M | -3.95M | -4.16M | -3.90M | -4.15M | -3.55M | |||||
| Net Debt | -12.84K | -23.97K | -37.14K | -10.91K | -20.20K | -22.27K | -76.24K | -14.96K | -172.70K | -23.49K | -247.22K | -51.33K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
HealthLynked Corp (HLYK) — SEC Financial Statements & Analysis
HealthLynked Corp (HLYK) is a services-offices & clinics of doctors of medicine company, incorporated in NV. HealthLynked Corp trades on OTC as: HLYK. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), HealthLynked Corp reported a -46.73% year-over-year revenue growth, a Gross Profit Margin of 55.53% (TTM), a Debt-to-Equity ratio of -1.21x, a Price-to-Sales (P/S) ratio of 6.43x (TTM), a Price-to-Book (P/B) ratio of -1.14x (TTM), at a market cap of $8.83M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -46.73%
- Gross Profit Margin TTM
- 55.53%
- Debt To Equity
- -1.21x
- P/S TTM
- 6.43x
- P/B TTM
- -1.14x
- Market Cap
- $8.83M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HealthLynked Corp in?
HealthLynked Corp (HLYK) operates in the Services-Offices & Clinics of Doctors of Medicine industry.
What is HLYK's market cap?
HealthLynked Corp (HLYK) has a market capitalization of $8.83M as of 2026-06-30.
What exchange does HLYK trade on?
HealthLynked Corp (HLYK) trades on the OTC.
Where is HealthLynked Corp incorporated?
HealthLynked Corp is incorporated in NV.